The pharmacokinetic profile of atomoxetine is highly dependent on cytochrome P450 2D6 genetic polymorphisms of the individual
It is significantly mor
Objectives: The purpose of this study was the assessment of Atomoxetine effectiveness and tolerability in the treatment of autistic features in patients with ASD
In the clinical trials for atomoxetine in children and adolescents, the most common side effects reported were upset stomach, decreased appetite, nausea or vomiting, dizziness, tiredness, and mood Strattera is the brand name for a medication called atomoxetine
We searched the database PubMed/MEDLINE (January 1, 2000 to October 1, 2021)
It may help to increase the ability Atomoxetine is prescribed to children with autism spectrum disorder having symptoms of attention deficit hyperactivity disorder
feeling unusually cold
Abstract
It has been suggested that efficacy of atomoxetine in the autism spectrum population should be
Key takeaways: Qelbree (extended-release viloxazine) and Strattera (atomoxetine) are two similar non-stimulant medications that can be used to treat attention-deficit hyperactivity disorder (ADHD)
Approval: 2002 WARNING: SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS See full prescribing information for complete boxed warning
If the mother of an older infant requires atomoxetine, it is not a reason to discontinue breastfeeding, but until more data become available, an alternate drug may